Introduction.
D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D001442:Bacteroides Infections / Q000188:drug therapy; D001441:Bacteroides fragilis / Q000187:drug effects; D002981:Clindamycin / Q000627:therapeutic use*; D006801:Humans
D000900:Anti-Bacterial Agents; D002981:Clindamycin